CDKV Holdings’s Colgate-Palmolive CL Stock Holding History

CDKV Holdings’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1K	Hold	110	–	–	0.01%	206
2026 Q1	$9.38K	Hold	110	–	–	0.01%	205
2025 Q4	$8.69K	Buy	+110	New	+$8.62K	0.01%	212

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CDKV Holdings's CL Position: Q2 2026 in Review

CDKV Holdings held its Colgate-Palmolive (CL) position steady in Q2 2026 at 110 shares worth $10.1K. The position accounts for 0.01% of the portfolio, ranked #206.

CDKV Holdings first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

CDKV Holdings held 110 shares of Colgate-Palmolive worth $10.1K as of Q2 2026.
CDKV Holdings left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.01% of CDKV Holdings's portfolio in Q2 2026, its #206 holding.
CDKV Holdings first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.